Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Goldberg

Showing results (1441-1450 of 1,605) with videos related to

Pageof 161
Sort By:
Clinical Psychology Review|February 19, 2013
Cognitive-behavioral therapy versus other therapies: reduxTimothy P Baardseth, Simon B Goldberg, Brian T Pace, et al.
The Journal of Extra-Corporeal Technology|June 18, 2024
Perfusion Measures and Outcomes (PERForm) registry: First annual reportDavid C Fitzgerald, Xiaoting Wu, Timothy A Dickinson, et al.
Journal of the American Heart Association|March 12, 2024
Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC StudyJustin B Echouffo-Tcheugui, Sui Zhang, Roberta Florido, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2019
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 AntibodyV Ellen Maher, Laura L Fernandes, Chana Weinstock, et al.
Journal of Visualized Experiments : Jove|May 19, 2011
Biomolecular detection employing the Interferometric Reflectance Imaging Sensor (IRIS)Carlos A Lopez, George G Daaboul, Sunmin Ahn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2001
Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodiesM A Lindorfer, A Nardin, P L Foley, et al.
Journal of the American College of Cardiology|August 7, 2013
Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes)John R Guyton, April E Slee, Todd Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2018
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast CancerLynn J Howie, Nancy S Scher, Laleh Amiri-Kordestani, et al.
Journal of the American Academy of Dermatology|July 21, 2018
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapyJacob Siegel, Mariam Totonchy, William Damsky, et al.
Nature Neuroscience|November 16, 2010
HCN channelopathy in external globus pallidus neurons in models of Parkinson's diseaseC Savio Chan, Kelly E Glajch, Tracy S Gertler, et al.
Pageof 161

Showing results (1441-1450 of 1,605) with videos related to

Sort By:
Pageof 161
Clinical Psychology Review|February 19, 2013
Cognitive-behavioral therapy versus other therapies: reduxTimothy P Baardseth, Simon B Goldberg, Brian T Pace, et al.
The Journal of Extra-Corporeal Technology|June 18, 2024
Perfusion Measures and Outcomes (PERForm) registry: First annual reportDavid C Fitzgerald, Xiaoting Wu, Timothy A Dickinson, et al.
Journal of the American Heart Association|March 12, 2024
Galectin-3, Metabolic Risk, and Incident Heart Failure: The ARIC StudyJustin B Echouffo-Tcheugui, Sui Zhang, Roberta Florido, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2019
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 AntibodyV Ellen Maher, Laura L Fernandes, Chana Weinstock, et al.
Journal of Visualized Experiments : Jove|May 19, 2011
Biomolecular detection employing the Interferometric Reflectance Imaging Sensor (IRIS)Carlos A Lopez, George G Daaboul, Sunmin Ahn, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2001
Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodiesM A Lindorfer, A Nardin, P L Foley, et al.
Journal of the American College of Cardiology|August 7, 2013
Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes)John R Guyton, April E Slee, Todd Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2018
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast CancerLynn J Howie, Nancy S Scher, Laleh Amiri-Kordestani, et al.
Journal of the American Academy of Dermatology|July 21, 2018
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapyJacob Siegel, Mariam Totonchy, William Damsky, et al.
Nature Neuroscience|November 16, 2010
HCN channelopathy in external globus pallidus neurons in models of Parkinson's diseaseC Savio Chan, Kelly E Glajch, Tracy S Gertler, et al.
Pageof 161